Taevas
VietnamMedical Devices
Product Registration
Market Access for Product-Registration in Vietnam
Navigating the complex global landscape of product registration requires a robust market access strategy. Taevas Life Sciences provides comprehensive solutions to ensure your innovative therapies achieve timely market entry and optimal commercial success
Market
Global
Industry
Product-Registration
Regulator
Diverse National Regulatory Bodies
Timeline
8-12 weeks (initial strategy)
Deliverables
Strategy Report, HTA/Reimbursement Dossier, Stakeholder Engagement Plan
What We Deliver
6 Pillars of Global Market Access for Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Regulatory & Market Landscape Analysis
Thorough analysis of target markets' regulatory requirements, HTA processes, and competitive landscapes to identify opportunities and challenges.
Global Regulatory Intelligence
Competitive & Payer Landscape Mapping
How It Works
Our Streamlined Global Market Access Process
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Landscape Assessment
We initiate with a deep dive into your product, therapeutic area, and target markets to understand the unique regulatory, clinical, and commercial landscape.
Market Snapshot
Market Overview: Global Product Registration & Access Dynamics
Increasing Regulatory Complexity
The global regulatory environment is becoming more fragmented and demanding, requiring precise market-specific strategies for successful product registration and market access.
Emphasis on Real-World Evidence
Payers and HTA bodies increasingly demand robust real-world evidence alongside clinical trial data to demonstrate long-term value and justify pricing, necessitating proactive evidence generation planning.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining strategic recommendations for achieving optimal market access across target regions.
Localized Value Dossier & HTA Submission Package
Tailored evidence packages designed to meet the specific requirements of HTA bodies and payers in individual countries.
Reimbursement Pathway Analysis
Detailed analysis of potential reimbursement routes, including pricing corridors, negotiation strategies, and anticipated access hurdles.
Stakeholder Mapping & Engagement Plan
Identification of key opinion leaders, patient groups, and payer organizations with a strategic plan for effective communication and collaboration.
Who This Is For
Use Cases
Orphan Drug
Launching a Novel Orphan Drug Globally
A biotech client sought to register and commercialize a rare disease therapy across North America, Europe, and Asia. Taevas developed a global market access strategy, including tailored HTA submissions and patient advocacy engagement plans for each region.
Outcome
Achieved accelerated registration and premium reimbursement in multiple key markets.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Accelerate Global Market Access for Your Product?
Partner with Taevas Life Sciences to transform your product registration into a pathway for global commercial success. Our experts are ready to guide you.
Access Global Expertise
Streamline Regulatory Pathways
Optimize Reimbursement Potential
Achieve Sustainable Market Presence